Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
Approved for use in oncology care according to FDA-approved indications.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Adjuvant treatment of HER2-overexpressing node-positive or node-negative breast cancer, metastatic HER2-overexpressing breast cancer, and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Adult Acute Lymphoblastic Leukemia (ALL), Burkitt Lymphoma, and Mantle Cell Lymphoma.